Heidi Founder Builds AI Medical Scribe

Dr. Thomas Kelly, co-founder and CEO of Heidi, has built an AI medical scribe that transcribes patient visits and generates clinical notes, aiming to reduce clinician administrative burden. The company announced a $65 million Series B in October, valuing Heidi at $465 million and bringing its total funding near $100 million, signaling investor confidence in clinical documentation automation.
Key Points
- 1Launches AI scribe that transcribes visits and generates clinical notes, reducing clinician administrative burden
- 2Raises $65 million Series B, valuing company at $465 million, signaling strong investor confidence
- 3Offers clinicians time savings and reduced burnout, enabling focus on patient care and follow-up
Scoring Rationale
Strong funding and clear clinical traction drive score, limited by incremental product innovation and single-company focus.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems

